May 3, 2018

CAAR – New England Journal of Medicine Article – May 3, 2018

Filed under: Reports and Articles — Tags: , — admin @ 4:55 pm

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease,” by Michael F. Egan, James Kost, Pierre N. Tariot, Paul S. Aisen, Jeffrey L. Cummings, Bruno Vellas, Cyrille Sur, Yuki Mukai, Tiffini Voss, Christine Furtek, Erin Mahoney, Lyn Harper Mozley, Rik Vandenberghe, Yi Mo, and David Michelson (Vol. 378, No. 18, May 3, 2018, p. 1691-1703).

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress